About the Authors
- Markus Thomas
-
* E-mail: markus.thomas@roche.com
Affiliation Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Yvonne Kienast
-
Affiliation Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Werner Scheuer
-
Affiliation Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Monika Bähner
-
Affiliation Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Klaus Kaluza
-
Affiliation Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Christian Gassner
-
Affiliation Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Frank Herting
-
Affiliation Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Ulrich Brinkmann
-
Affiliation Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Stefan Seeber
-
Affiliation Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Anita Kavlie
-
Affiliation Affitech Research AS, Oslo, Norway
- Martin Welschof
-
Current address: Opsona Therapeutics Ltd., Dublin, Ireland
Affiliation Affitech Research AS, Oslo, Norway
- Stefan Ries
-
Affiliation Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- K. Michael Weidner
-
Affiliation Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Jörg T. Regula
-
Affiliation Biologics Research, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Christian Klein
-
Current address: Discovery Oncology, Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland
Affiliation Discovery Oncology, Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
Competing Interests
The authors are employees of Roche Diagnostics GmbH or Affitech Research AS. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MT YK WS MB KK CG FH UB SS SR KMW JTR CK. Performed the experiments: MT YK WS KK CG FH SS JTR. Analyzed the data: MT YK WS KK CG FH SS JTR CK. Contributed reagents/materials/analysis tools: MB AK MW. Wrote the paper: MT YK CK.